APPROVABLE LETTERS IN THE FDA NEW DRUG APPROVAL PROCESS

被引：0

|

作者：

RICHARD, BW

ULCICKAS, M

LASAGNA, L

机构：

来源：

JOURNAL OF CLINICAL PHARMACOLOGY | 1989年 / 29卷 / 08期

关键词：

D O I：

10.1002/j.1552-4604.1989.tb03402.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：680 / 684

页数：5

相关论文

共 50 条

[21] MITOXANTRONE AND THE NEW DRUG APPROVAL PROCESS
ABELOFF, MD
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (05) : 551 - 553
[22] New drug approval process in Japan
Hayakawa, T
CURRENT OPINION IN BIOTECHNOLOGY, 1999, 10 (03) : 307 - 311
[23] NEW DRUG APPROVAL PROCESS FOR RADIOPHARMACEUTICALS
SHEININ, EB
KISHORE, R
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1990, 200 : 157 - NUCL
[24] Expediting the drug approval process: An analysis of the FDA Modernization Act of 1997
Parver, DG
ADMINISTRATIVE LAW REVIEW, 1999, 51 (04) : 1249 - 1266
[25] FDA comes under scrutiny - Drug trials, approval process questioned
不详
AMERICAN JOURNAL OF NURSING, 2005, 105 (06) : 29 - 30
[26] How to access and process FDA drug approval packages for use in research
Turner, Erick H.
BMJ-BRITISH MEDICAL JOURNAL, 2013, 347
[27] NEW FDA DRUG APPROVAL POLICIES AND HIV VACCINE DEVELOPMENT
MARINER, WK
AMERICAN JOURNAL OF PUBLIC HEALTH, 1990, 80 (03) : 336 - 341
[28] FDA's Expedited Approval Mechanisms for New Drug Products
Kepplinger, Erin E.
BIOTECHNOLOGY LAW REPORT, 2015, 34 (01) : 15 - 37
[29] Carvedilol and the food and drug administration (FDA) approval process: The FDA paradigm and reflections on hypothesis testing
Fisher, LD
CONTROLLED CLINICAL TRIALS, 1999, 20 (01): : 16 - 39
[30] Crawford seeks to restore confidence in FDA approval process - Drug safety and access top the priority list for new FDA commissioner
不详
FORMULARY, 2005, 40 (08) : 257 - 257

← 1 2 3 4 5 →